KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Prepaid Assets (2017 - 2025)

Moderna (MRNA) has disclosed Prepaid Assets for 8 consecutive years, with $45.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Prepaid Assets changed N/A to $45.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $45.0 million, a N/A change, with the full-year FY2025 number at $45.0 million, changed N/A from a year prior.
  • Prepaid Assets was $45.0 million for Q4 2025 at Moderna, down from $56.0 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $728.0 million in Q4 2021 to a low of $44.0 million in Q4 2022.
  • A 5-year average of $297.2 million and a median of $196.0 million in 2021 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: skyrocketed 3366.67% in 2021, then crashed 93.96% in 2022.
  • Moderna's Prepaid Assets stood at $728.0 million in 2021, then plummeted by 93.96% to $44.0 million in 2022, then soared by 1325.0% to $627.0 million in 2023, then fell by 2.55% to $611.0 million in 2024, then plummeted by 92.64% to $45.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRNA's Prepaid Assets are $45.0 million (Q4 2025), $56.0 million (Q3 2025), and $57.0 million (Q2 2025).